Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Open in API
Filings indexed 2,572 across all filing types
Latest filing 2021-08-05 Earnings Release
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 5, 2021, reporting the issuance of a press release announcing financial results for the second quarter ended July 4, 2021. The text explicitly states that the press release is attached as Exhibit 99.1 and that the information is furnished under Item 2.02 Results of Operations and Financial Condition. The document itself is a current report notifying the market of the earnings release, not the earnings release document itself. The length is 3889 characters, which is relatively short and consistent with an 8-K filing announcing earnings results rather than the full earnings report. According to the classification rules, initial announcements of quarterly financial results (key highlights only) correspond to Earnings Release (ER). Since this is a Form 8-K announcing the earnings release, it fits best under Earnings Release (ER).
2021-08-05 English
425 Filing
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for Illumina, Inc. for the second quarter of 2021. It includes prepared remarks from the CEO and CFO discussing financial results, revenue growth, segment performance, and outlook. The text explicitly mentions it is the "earnings call" and contains detailed financial commentary and Q&A format indications. This matches the definition of a Call Transcript (CT), which is a full text transcript of company conference calls such as earnings calls. The document length is substantial (15,000 characters), and it contains actual financial data and management discussion, not just a brief announcement or summary. Therefore, the correct classification is CT with high confidence.
2021-08-05 English
PRIMARY DOCUMENT
Director's Dealing
2021-07-29 English
PRIMARY DOCUMENT
Director's Dealing
2021-07-26 English
425 Filing
M&A Activity Classification · 95% confidence The document is a press release issued by Illumina, Inc. regarding its commitment to re-acquire GRAIL and related regulatory and legal matters. It references filings with the SEC such as Form S-4 and registration statements related to the transaction, but the document itself is a communication about the transaction status and regulatory challenges, not the actual filings or financial reports. It does not contain financial statements or detailed financial data, nor is it a transcript, management report, or proxy statement. The document is an announcement related to merger activity and regulatory process, but it is not a formal merger filing like a DEFM14A or SC TO-*. Given the content and context, the best fitting category is M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids. The document is substantive and over 10,000 characters, so it is not a mere report publication announcement or regulatory filing. Confidence is high due to clear references to merger and acquisition context and regulatory filings related to the transaction.
2021-07-22 English
PRIMARY DOCUMENT
Director's Dealing
2021-07-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.